TNIP2 and pulmonary arterial hypertension: Through the use of patient-derived cells and in vitro gene knockdown studies, we show that TNIP2 and TRAF2 act by suppressing the activation of NF-κB, a transcription complex that controls the expression of inflammatory cytokines and genes associated with cell proliferation in PAH (18–21).